Clinical Trial Update: Expanded Access for KHK2455

View source ↗

Summary

Expanded Access for Kyowa Kirin's KHK2455 in glioblastoma multiforme is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• KHK2455

Snippet

Sponsor: Kyowa Kirin, Inc. | Conditions: Glioblastoma Multiforme | Status: NO_LONGER_AVAILABLE